EyePoint (EYPT) Gross Profit (2018 - 2026)
EyePoint (EYPT) posted Gross Profit of $168000.0 for Q1 2026, down 31.43% sequentially from $245000.0 in Q4 2025, and down 99.29% YoY from $23.6 million in Q1 2025.
Analysis
EyePoint (EYPT) Gross Profit (2018 - 2026) Analysis & Trends
EyePoint has reported Gross Profit for 9 years, with the latest figure at $168000.0 in Q1 2026.
- Quarterly Gross Profit fell 99.29% year-over-year to $168000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.8 million (down 88.86% YoY) and the FY2025 annual result came in at $29.3 million, down 25.92% from the prior year.
- Gross Profit slipped to $168000.0 in Q1 2026 per EYPT's latest filing, from $245000.0 in the prior quarter.
- Over five years, Gross Profit peaked at $23.6 million in Q1 2025 and troughed at $168000.0 in Q1 2026.
- A 5-year average of $8.4 million and a median of $8.1 million in 2024 frame the typical range for Gross Profit.
- The sharpest annual moves came in 2025 and 2026: Gross Profit soared 116.46% in 2025, then sank 99.29% in 2026.
- Over 5 years, Gross Profit stood at $7.1 million in 2022, then surged by 82.93% to $13.0 million in 2023, then slipped by 17.33% to $10.8 million in 2024, then tumbled by 97.73% to $245000.0 in 2025, then plunged by 31.43% to $168000.0 in 2026.
- According to Business Quant data, Gross Profit over the past three periods registered $168000.0, $245000.0, and $245000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | EyePoint | 398.53 Mn | 218.06 Mn | 507,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 507,000.00 |
| Mar 31, 2026 | 168,000.00 |
| Dec 31, 2025 | 245,000.00 |
| Sep 30, 2025 | 245,000.00 |
| Jun 30, 2025 | 5.17 Mn |
| Mar 31, 2025 | 23.65 Mn |
| Dec 31, 2024 | 10.77 Mn |
| Sep 30, 2024 | 9.79 Mn |
| Jun 30, 2024 | 8.08 Mn |
| Mar 31, 2024 | 10.93 Mn |
| Dec 31, 2023 | 13.03 Mn |
| Sep 30, 2023 | 14.00 Mn |
| Jun 30, 2023 | 7.31 Mn |
| Mar 31, 2023 | 7.04 Mn |
| Dec 31, 2022 | 7.12 Mn |
| Sep 30, 2022 | 8.61 Mn |
| Jun 30, 2022 | 9.83 Mn |
| Mar 31, 2022 | 7.52 Mn |
| Dec 31, 2021 | 8.51 Mn |
| Sep 30, 2021 | 7.23 Mn |